Diketopiperazines are the smallest cyclic peptides known. 90% of Gram-negative bacteria produce diketopiperazines and they have also been isolated from Gram-positive bacteria, fungi and higher organisms.
Introduction
(1)
(17) All compounds were weakly antibacterial inhibiting the growth of Staphylococcus aureus and Micrococcus luteus at the concentration of 2.9 mmol l -1 [39] . From the blowfly, Lucilia sericata, cyclo(L-Pro-L-Pro) 7 has been isolated and has been demonstrated to have antibacterial activities against Pseudomonas aeruginosa and Micrococcus luteus [40] . From a Psychrobacter species in total sixteen different diketopiperazines have been isolated but only cyclo(L-Phe-L-Pro) 5 showed a protective effect against Vibrio vulnificus and induced cytotoxicity in human intestinal epithelial cells [41] . Cyclo(L-Arg-L-Leu) 11 was reported from a Streptomyces species and found to have antibacterial and antifungal activities [42] . Cyclo(D-Trp-L-Trp) 12 has been isolated from Penicillium fellutanum and named fellutanine A [43] . The same compound has also been isolated from a Streptomyces species and shown to be active against clinical multidrugresistant Acinetobacter baumannii strains. Interestingly, the antibacterial activity was only seen for some A.
baumannii isolates while the growth of others was not hindered [44] . The antimicrobial diketopiperazines cyclo(L-Leu-trans-4-OH-L-Pro) 9, cyclo(D-Leu-trans-4-OH-L-Pro) 13, and cyclo(L-Phe-cis-4-OH-D-Pro) 14
were characterized from the actinomycete Saccharothrix espanaensis isolated from a marine mollusk [45] . , is a dihydroxamic acid and binds strongly iron [47] . Because iron is essential for microbes this compound acts like a growth factor and this may also have an antimicrobial effect in microbial communities. The diketopiperazine antibiotic CJ-17,665 22 has been isolated from Aspergillus ochraceus and was able to inhibit growth of multi-drug resistant Staphylococcus aureus, Streptococcus pyogenes and Enterococcus faecalis [48] . This unusual antibiotic contains a bridged diketopiperazine and the rare N-oxide moiety. The cyclo(L-Ala-L-Try) derivative echinuline 23 isolated from Aspergillus amstelodami [49] has been found to be active against Mycobacterium tuberculosis [50] . From several Penicillium species roquefortine C 24 has been isolated. Roqueforine C possesses antibacterial activity against a number of gram-positive bacteria [51] showing MIC of 6.3 µg ml -1 against Bacillus subtilis. However, the closely related roquefortine E 25 which differs from roquefortine C only by an additional hemiterpene moiety did not show any microbial activity [52] .
Cyclomarazines A 26 and B 27 were discovered in the culture broth of Salinispora arenicola. [55] .
Albonursin was also detected in Streptomyces albulus, which also produced the biosynthetic intermediates (Z)-3-benzylidene-6-isobutyl-30 and (Z)-3-benzyl-6-isobutylidene-diketopiperazine 31. Contrary to albonoursin these intermediate had neither antibacterial nor cytotoxic activities, indicating that dehydrogenation at the α,β-positions of both amino acids are required for bioactivity [56] .
Many epipolythiodiketopiperazines are known from fungi which are phytotoxins [57] . They comprise well studied compounds like gliotoxin 32 [58] , sirodesmin PL 33 or chaetomin 34 [59] (Figure 3 ). Most of them are also antimicrobial and for sideromin PL antibacterial activities against Gram-positive bacteria [60] and antifungal activities have been described [61] . Gram-negative bacteria or fungi but they strongly suppressed the growth of various murine and human tumour cells and induced apoptosis [63] . The antibacterial and antifungal activities of many of these epipolythiodioxopiperazines are interesting but due to their high toxicity in mammals they have not been considered as lead for drug development.
Diketopiperazines comprise also classical antibiotics and one of the best known examples is the unusual natural product bicyclomycin 40 ( Figure 2 ). Bicyclomycin is an antibiotic produced by Streptomyces sapporonensis and S. aizunensis and has been developed and marketed as bicozamycin by Fujisawa. Its low toxicity (LD 50 > 4 g kg -1 in mice) allows its application as an effective drug against nonspecific diarrhea in humans. It has a unique chemical structure comprising a diketopiperazine moiety [64] . It exhibits activity against a broad spectrum of Gram-negative bacteria with the noteworthy exception of Proteus species and Pseudomonas aeruginosa and is active against the Gram-positive bacterium Micrococcus luteus [65] . The mechanism of action of bicyclomycin is novel because it targets the rho transcription termination factor and bicyclomycin is the only known selective inhibitor of rho. Rho is a member of the RecA-type ATPase class of enzymes that couple oligonucleotide translocation to ATP hydrolysis. The rho protein is integral to the expression of many gene products in Escherichia coli and other Gram-negative bacteria, and without rho the cell losses viability due to overproduction of proteins [66] . No clear structure-activity relationship has emerged from the biological activities of bicyclomycin derivates and a Ciba-Geigy group has found that most structural modifications result although the activities were weak [72] .
Diketopiperazines as antifungal agents
Besides having antibacterial activities many diketopiperazines have been isolated and characterized because of antifungal activities [73] . It has been reported that cyclo( mg ml -1 [76] . From the same species cyclo(Val-Val) of unknown stereochemistry has been identified and shown to inhibit Aspergillus flavus growth [77] . The derivatised diketopiperazine mactanamide 46 ( Figure 2 ) has been isolated from a marine Aspergillus species. It showed fungistatic properties, however, no details have been given in the report [78] . Etzionin 47 has been isolated from an unidentified Red Sea tunicate. It is an unusual diketopiperazine bearing a hydroxamate and a long aliphatic side chain. Etzionin has antifungal properties inhibiting Candida albicans with MIC of 3 µg ml -1 and showing also inhibition against Aspergillus nidulans and the bacterium Bacillus subtilis [79] but the compound has also cytotoxic activity. From a Bacillus species isolated from a sea urchin five diketopiperazines, bacillusamides A and
, and cyclo(L-Pro-L-Tyr) 44 were isolated. Only bacillusamide 48 showed weak antifungal activity against
Aspergillus niger [80] .
The antibacterial activity of many epipolythiodiketopiperazines has been already discussed but many of them possess also antifungal properties. In an interesting in vivo model system a number of natural metabolites were tested for antifungal activities. The model comprised the infection of Caenorhabditis elegans with the yeast Candida albicans and allowed the determination of both the antifungal activity and the cytotoxicity of the compounds. In this screen the acetylgliotoxin 49 and epipolypiperazinedione 50 were found to possess the highest activities to protect C. elegans. No cytotoxicity was observed for the epipolypiperazinedione 50 [81] .
The homologues compounds A26771A (=hyalodendrin [82] ) 51, and A26771C 52 (Figure 3 ), isolated from
Penicillium turbatum, were also reported to have antibacterial and antiviral properties but data on the cytotoxicity were not given [83] .
Some diketopiperazines have also anti-viral activities
From the fungus Alternaria raphania the dihydrooxepine-bearing diketopiperazines acetylaranotin 53, alternarosin A 54 ( Figure 3 ) bisdethiodi(methylthio)acetylaranotin, and cyclo-(Pro-Tyr) of unknown configuration were characterized [84] . The production of acetylaranotin, here named LL-S88α, was also reported from Aspergillus terreus [85] and its absolute configuration was determined by X-ray crystallography [86] . The closely related alternarosin A showed weak antibacterial (MIC 203 µM against Escherichia coli and Bacillus subtilis) and weak antifungal characteristics (MIC 406 µM against Candida albicans) but stronger cytotoxic activities [87] . More interesting is the antiviral activity reported for gliotoxin 32, acetylaranotin 53 and the synthetic compound N,N'-dimethylepidithiadiketopiperazine 55 [88] . The antiviral activity of these compounds was reported 4 years earlier by another group which showed also that these compound cannot be used for any clinical applications because of their high toxicity and low water solubility [89] . Gliotoxin 32 and related compounds were reported to display antiviral activities both in their oxidized and reduced forms. Because the antiviral activity disappeared when the reduced state was maintained by the addition of large amounts of reducing agents or after reductive methylation of acetylgliotoxin 49 to 56 the apparent activity of the dithiol was due to cellular oxidation to the dithio-derivative [90] .
To develop antiviral drugs one has not to start only from natural products but one can also develop a drug for clinical trials starting from a chemical library. The human immuno-deficiency virus type 1, HIV-1, required the human receptor CCR5 for infection. Therefore, blocking this receptor may offer a novel alternative for controlling HIV infections although other viruses may benefit from such a treatment [91] . Screening a library of spiro-diketopiperazines compound 913 57 ( Figure 4 ) was identified blocking the binding of macrophage inflammatory protein-1 to CCR5 (IC 50 2 nM) inhibiting the replication of some but not all HIV-1 variants [92] .
Beside 57 some other compounds from this library showed also promising activities [93] and were developed further. From these studies compound 58 emerged which was five times more active in the binding assay and 50 times more active in the HIV assay than the non-hydroxylated analogue 59. Remarkable is the tight stereochemical control of the activity. While the S-enantiomer of 59 is three times more active than its mirror compound the contrary is the case for 58 [94] . Intensive analyses of the pharmacokinetic profiles of these and related compounds [95] , introduction of a terminal carboxylic acid function together with a structure-activity relationships study [96] , led finally to the development of the potent orally available CCR5 antagonist 60 [97, 98] . Figure 3 ) [99] . From these compounds only gliotoxin showed inhibition of the trypanosomal cathepsin TbCatB, which is essential for the survival of the parasite. The activity of the epipolythiodiketopiperazines against T. brucei has, however, to be put into context with their cytotoxicity as mentioned before and any practical use has to be evaluated in this light.
Diketopiperazines as biofilm interfering drugs
Bacteria can adhere to inert or living surfaces, forming structured microbial communities where microorganisms are embedded in a matrix of extracellular polymers (EPS), proteins and DNA, known as biofilms. They represent a protected means of growth that allows survival in a hostile environment and can involve a single microbial species but usually harbor microbial communities [100, 101] . Biofilm formation is associated with several chronic diseases and the results of this colonization are persistent infections that are hard and even impossible to treat, leading to severe health complications and longer hospital stays [102, 103] .
Microorganisms can communicate with each other, in a phenomenon known as quorum sensing (QS), a mechanism used by many bacteria to perceive and respond to environmental factors. QS is mediated by the production and subsequent recognition of small molecules called autoinducers, e. g. N-acyl homoserine lactones (AHL), for Gram-negative and oligopeptides for Gram-positive bacteria [104] .
QS is used to synchronize gene expression and regulate the numerous processes that are involved in community behavior and virulence. The majority of the behaviors controlled by quorum-sensing are much more productive when bacteria express them in synchrony; these behaviors include bioluminescence, EPS production, sporulation, conjugation, and pigment production. However, in pathogenic microorganisms these changes in gene expression allow bacteria also to coordinate the expression of virulence genes and to minimize the impact of the host immune system until a proper number of microorganisms develops in order to establish infection [104, 105] . In 2005, Henzer et al. compared transcriptomic profiles of Pseudomonas aeruginosa growing as biofilm and concluded that it is not possible to deduce if biofilm formation is a QS behavior or an adaptative response to environmental conditions [106] . This finding and those from other researchers were also discussed by Bjarnsholt et al. [107] . Nevertheless, the importance of QS in P. aeruginosa virulence was shown by Jensen et al., who demonstrated that the bacteria can protect themselves by killing polymorphonuclear leucocytes (PMNs) by the production of rhamnolipid B, a QS controlled behavior [108] . Biomaterial-associated infections are caused mostly by biofilm-forming staphylococci, such as Staphylococcus epidermidis and S. aureus. These microorganisms, when growing in biofilms are much more resistant to antibiotics than planktonic cells [109] .
Usually, patients with this kind of infection are treated with various antibiotics, often without success. Therefore, a replacement of the infected implant is usually required, leading to substantial morbidity and mortality [110, 111] .
Essential elements in the role of biofilm formation has been evaluated as targets to new drugs, which includes surface modifications of the medical devices to prevent the bacterial attachment and the use of catheters with antimicrobial agents. However, the recurrent infections remain frequent, putting emphasis on the need for new compounds effective against biofilms [112] .
Interfering with communication
From a Ruegeria species associated with a sponge no less than ten different diketopiperazines, cyclo(L-
69 and cyclo(L-4-OH-Pro-L-Val) 70 ( Figure 1 ) have been isolated [113] . It has been speculated by the authors that they are involved in bacteria -host communication but no experimental proof for this assumption has been shown. Sphingomonas species and Aspergillus fumigatus, when co-cultured, lead to isolation of the epipolythiodiketopiperazine glionitrin A 71 (Figure 3) , harboring a nitro group at the aromatic ring. It possessed significant antibiotic activity against a series of bacteria including methicillin-resistant S. aureus and against A.
fumigatus. Furthermore, in vitro cytotoxicity assay revealed that glionitrin A had submicromolar cytotoxic activity against four human cancer cell lines [114] . When challenged by co-culture with another Bacillus species the Bacillus UA-094 isolate produced among other compounds cyclo-Phe-Pro of unreported stereochemistry [115] . [116] . Therefore, bacterial diketopiperazines may have an influence on the eukaryotic host-bacteria, resp. human-pathogen, interactions as well [8] .
Diketopiperazines as agonists and antagonists QS autoinducers
A number of reports of interference of diketopiperazines with the QS system have been made, although some of them were conflicting. Cyclo(L-Pro-L-Tyr) 44 and cyclo(dehydro-Ala-L-Val) 72 ( Figure 1 ) have been isolated from the culture supernatants of P. aeruginosa. These compounds were also produced by a marine found in Pseudomonas fluorescens and P. alcaligenes, instead, both pseudomonads produced cyclo(L-Phe-L-
and cyclo(L-Leu-L-VaL) 72, were found in Pseudomonas putida WCS358, where cyclo(L-Leu-L-Pro) 4 and cyclo(L-Pro-L-Tyr) 44 were able to activate the biosensor strain Agrobacterium tumefaciens NT1(pDCI41E33) [117, 118, 119] . Holden et al., showed that the dipeptide cyclo(L-Pro-L-Val) 8 can activate QS demonstrated by violacein production in the mutant strain of Chromobacterium violaceum (CV026) [117] . All three diketopiperazines activate the homoserine quorum sensing biosensor in a concentration-dependent manner, but much higher concentrations were required than for the natural activator N-(3-oxohexanoyl) -L-homoserine lactone (C6-HSL). Mechanism studies revealed that the three diketopiperazines antagonise the C6-HSL mediated induction of bioluminescence, suggesting that they compete for the same binding site [117] . Cyclo(L-Phe-L-Pro) 5 produced by Vibrio vulnificus was able to activate the quorum sensing on an E. coli biosensor strain. This diketopiperazine affects the expression of the ompU and ctx genes, enhancing the expression of OmpU proteins.
OmpU is implicated in several pathogenicity factors, like resistance to antimicrobials and bile acids, organic acid tolerance, biofilm formation, attachment to host cells in symbiotic relationships and adhesion [120] .
Diketopiperazines interfering with QS are not limited to bacteria but were also found in archaea in 2011. Five
and cyclo(L-Pro-L-Ile) 74, were isolated from the Haloterrigena hispanica and it was demonstrated that cyclo(LPro-L-Val) 8 activated the QS system in Vibrio anguillarum DM27 shown by the production of the green fluorescent protein Gfp. As already reported in the literature, for the Gfp expression in the V.anguillarum biosensor a much higher concentration of diketopiperazine was required than the C6-HSL standard (2.5 mM of diketopiperazine with respect to 50 nM of C6-HSL) [121] . In this context it is noteworthy to remember that some of these diketopiperazines are also known from fungi and plants including the fungi Rosellinia necatrix, cyclo(L- 44, produced by Lactobacillus reuteri, it has recently been shown that they strongly inhibit the Ptst promoter of the agr system of S. aureus. Interestingly, this is the case for all four known agr subgroups of S. aureus despite the differences in their autoinducer structures [123] . inhibiting activities. Furthermore, they found that these compounds did not compete with AHL for their receptor [124] . This study raises significant doubts that diketopiperazines act as QS signals at least in the test strain used.
Nevertheless, at the same time they open the door to systematic structure-activity studies on QS control by diketopiperazines [125] . The authors opened this door further by constructing a diketopiperazine macroarray consisting of 400 different compounds. They tested these compounds against the luminescence of Vibrio fischeri. It turned out that only six of them were inhibitor of the luminescence and none was found acting as agonist. The active compounds 80 -85 contain either glycine, isoleucine or phenylalanine but similar compounds where these amino acids have been replaced either by alanine or 4-chloro-phenylalanine were not active [126] ( Figure 5 ).
Outlook
Already a large diversity of natural diektopiperazines have been reported but because only still a small fraction of organisms have been explored much more can be expected. The chemical diversity of natural diketopiperazines is high and there are also several recent reports on novel diketopiperazines of unknown functions and activities which widens the diversity of this class of compounds. Recently, the diketopiperazines pre-aurantiamine 86 and aurantiamine 87 have been reported from a marine Aspergillus aculeatus isolate [127] ( Figure 6 ). However, no antimicrobial activities have been reported. Aurantiamine is also known from Penicillium aurantiogriseum [128] . It is an isomer of viridamine 88 [129] and interferes with the mitochondrial respiratory chain [130] . Also no biological activities are known for the tryptophan-derived isomeric novoamauromine 89 and ent-cycloechinulin 90 which were isolated from Aspergillus novofumigatus [131] . From the fungus Chromocleista species six diketopiperazines of unreported biological activities were identified: the novel epimeric diketopiperazines cyclo(L-Phe-2-OH-Pro) 91 and 92 and the known compounds cyclo(L-Leu-L- [132] . For Sch 54794 93, isolated from a Nigrospora species, no antibacterial activity against Staphylococcus aureus below 200 µg ml -1 could be detected but other bacteria seem to have not been tested [133] . These are some examples of novel diketopiperazines and it can be expected for the future that many more will be identified and hopefully tested for their antimicrobial activities. [46] . The LL-enantiomer was also described in the literature and tested against other bacteria than V.
anguillarum showing weak activity against S. aureus and M. luteus [40] . The authors concluded that because of 
L-Tyr
activities for the synthetic analogues. The authors hypothesized that this was due to cross talks between different signaling systems [117] . This was confirmed by Park et al. showing that cyclo(L-Phe-L-Pro) 5 affected the expression of the genes ompU and ctxAB in Vibrio species. Currently these conflicting results can be interpreted that diketopiperazines are probably no autoinducers as it was described in the past, but evidences strongly suggest that these compounds can interfere with QS products. However, it should be noted here that all these effects require much higher concentrations than those of the natural autoinducers.
What can be the future for diketopiperazines? For diepipolythio-diketopiperazines many interesting properties have been reported but all reports also caution that these compounds are all too toxic to give useful leads for drug development. One ecological function of a number of natural diketopiperazines seems to be the protection of the producing organism against virus infections. These compounds display indeed antiviral activities but diketopiperazines seems to have no good perspective as antivirals because currently there are better drugs available. The compounds 57 -60 ( Figure 4 ) may form an exception but the entire approach blocking the human CCR5 receptor for HIV replication but weakening at the same time the human immune system and fostering other viral infections, e. g. hepatitis C, seems to be questionable.
We see an important role for diketopiperazines in controlling biofilm infections. It has already been reported that they are important for interspecies communication and it would be very interesting to determine whether they also influence and shape the communication between pathogens [137] and between the pathogens and the human host. The results on the bacteria-bacteria communications controlled by diketopiperazines are already impressive. They comprise both the suppression of other bacteria and fungi and the induction of the production on bioactive compounds which then interfere with the behavior of pathogens. Currently, these results are still scarce and need systematic exploration and considerable increase of the activities of the antagonists. We are very optimistic that at the end diketopiperazines will be valuable drug to control biofilm infections acting as antibiofilm drugs.
